JP Morgan Chase’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-101
| Closed | -$93 | – | 7907 |
|
|
2024
Q1 | $93 | Hold |
101
| – | – | ﹤0.01% | 6918 |
|
|
2023
Q4 | $207 | Hold |
101
| – | – | ﹤0.01% | 7047 |
|
|
2023
Q3 | $368 | Buy |
101
+100
| +10,000% | +$433 | ﹤0.01% | 6764 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 6850 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7551 |
|
|
2022
Q4 | $0 | Buy |
+1
| New | +$6 | ﹤0.01% | 7386 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7122 |
|
|
2022
Q2 | – | Sell |
-305
| Closed | -$22.7K | – | 7160 |
|
|
2022
Q1 | $43K | Buy |
305
+65
| +27% | +$9.49K | ﹤0.01% | 5855 |
|
|
2021
Q4 | $41K | Sell |
240
-31
| -11% | -$11.6K | ﹤0.01% | 6017 |
|
|
2021
Q3 | $134K | Buy |
271
+28
| +12% | +$13K | ﹤0.01% | 5424 |
|
|
2021
Q2 | $122K | Buy |
+243
| New | +$131K | ﹤0.01% | 5474 |
|
|
2019
Q2 | – | Sell |
-80
| Closed | -$13K | – | 6105 |
|
|
2019
Q1 | $13K | Sell |
80
-3
| -4% | -$514 | ﹤0.01% | 5505 |
|
|
2018
Q4 | $10K | Buy |
83
+7
| +9% | +$1.07K | ﹤0.01% | 5444 |
|
|
2018
Q3 | $12K | Buy |
76
+22
| +41% | +$9.2K | ﹤0.01% | 5489 |
|
|
2018
Q2 | $35K | Buy |
+54
| New | +$40.4K | ﹤0.01% | 5195 |
|
|
2017
Q4 | – | Sell |
-6
| Closed | -$1K | – | 5639 |
|
|
2017
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 4925 |
|
|
2017
Q2 | $1K | Buy |
+6
| New | +$1.21K | ﹤0.01% | 4901 |
|
|
2017
Q1 | – | Sell |
-38
| Closed | -$10K | – | 5301 |
|
|
2016
Q4 | $10K | Buy |
+38
| New | +$9.05K | ﹤0.01% | 4803 |
|
Other funds holding AMPE
JP Morgan Chase's AMPE Position: Q2 2024 in Review
JP Morgan Chase sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 101 shares — an estimated $93 sold.
JP Morgan Chase first reported a position in AMPE in Q4 2016 and held it in 17 quarters. The position peaked at $134K in Q3 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.
- JP Morgan Chase reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
- JP Morgan Chase sold 101 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $93.
- JP Morgan Chase first reported a position in Ampio Pharmaceuticals Inc. in Q4 2016 and held it in 17 quarters.
- JP Morgan Chase's Ampio Pharmaceuticals Inc. position peaked at $134K in Q3 2021.
- 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.